This article highlights the role of the patient in the selection of sequential therapy for multiple sclerosis through the examination of two clinical case examples. The first case presents a patient with an exacerbation of relapsing-remitting multiple sclerosis, who was irregularly taking an oral medication administered twice a day. The second case describes a patient who experienced numerous side effects of the drug, which was administered via intramuscular injections. In both patients, due to clinical indications, a change of therapy was implemented. The key factor in selecting the medication was identifying the problems and complaints related to the current therapy, determining treatment priorities for the patients, and then individually modifying the treatment. Following the change, an improvement was observed in terms of compliance, with very good clinical and radiological control of disease progression and increased patient satisfaction.

disease modifying therapies, multiple sclerosis, adherence, highly individualised therapeutic strategies, injectable therapies